Transmedics Group Inc (TMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 190,291 | 35,464 | -25,028 | -36,231 | -44,215 |
| Depreciation Amortization | 27,185 | 19,758 | 8,177 | 3,478 | 1,817 |
| Income taxes - deferred | -83,543 | N/A | -1,660 | N/A | N/A |
| Accounts receivable | 13,950 | -34,310 | -33,816 | -21,678 | 840 |
| Accounts payable and accrued liabilities | -19 | -1,396 | 6,957 | -3,270 | 5,090 |
| Other Working Capital | 18,376 | -45,000 | -44,347 | -26,759 | 3,003 |
| Other Operating Activity | 26,600 | 74,287 | 76,689 | 38,643 | 4,601 |
| Operating Cash Flow | $192,840 | $48,803 | $-13,028 | $-45,817 | $-28,864 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -10,496 | -72,024 |
| PPE Investments | -59,251 | -129,744 | -179,059 | -11,907 | -3,519 |
| Net Acquisitions | N/A | 441 | -14,894 | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 76,916 | 104,810 |
| Investing Cash Flow | $-59,251 | $-129,303 | $-193,953 | $54,513 | $29,267 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 445,380 | 58,509 | N/A |
| Debt Repayment | N/A | N/A | -52,072 | -36,050 | N/A |
| Common Stock Issued | 16,995 | 22,874 | 7,110 | 145,468 | 1,393 |
| Other Financing Activity | -138 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $16,857 | $22,874 | $400,418 | $167,927 | $1,393 |
| Exchange Rate Effect | 1,270 | -536 | 193 | -1,021 | -797 |
| Beginning Cash Position | 337,150 | 395,312 | 201,682 | 26,080 | 25,081 |
| End Cash Position | 488,866 | 337,150 | 395,312 | 201,682 | 26,080 |
| Net Cash Flow | $151,716 | $-58,162 | $193,630 | $175,602 | $999 |
| Free Cash Flow | |||||
| Operating Cash Flow | 192,840 | 48,803 | -13,028 | -45,817 | -28,864 |
| Capital Expenditure | -59,251 | -129,744 | -179,059 | -11,907 | -3,519 |
| Free Cash Flow | 133,589 | -80,941 | -192,087 | -57,724 | -32,383 |